Sign in →

Test Code DBIL Direct Bilirubin

Important Note

Protect specimens from light. 

Additional Codes

Cerner

NextGen

Bilirubin Direct

Bilirubin Direct

Bili D

 

BiliD

 

Alternate Name(s)

Conjugated Bilirubin

Useful For

The direct bilirubin is the terminology that represents the classic representation of conjugated bilirubin, that is, bilirubin bound to the glucuronide.  It is important to determine whether the liver cells are conjugating the bilirubin that is present in the serum in order to be able to differentiate causes for an increased bilirubin level.

               

Jaundice has been classified as unconjugated and conjugated hyperbilirubinemia.  Increased plasma-unconjugated bilirubin is commonly seen in hemolytic disorders, Gilbert’s syndrome, Crigler-Najjar syndrome, neonatal jaundice, and ineffective erythropoiesis and in the presence of drugs competing for glucuronide.  Increased plasma-conjugated bilirubin occurs with hepatobiliary disorders, including intrahepatic and extrahepatic biliary tree obstruction, liver cell damage, Dubin-Johnson syndrome and Rotor syndrome.

Methodology

End-point colorimetric (dual-wavelength).

Patient Preparation

None

Collection Instructions

Standard phlebotomy practices.

Specimen should be protected from light.

Specimen Requirements

Container

Specimen Type

Tube

Lithium Heparin Plasma

PST

 or  or 

Serum

 or 

SST

 or  or 

 

Stability

Storage

Temperature

Stability

Room Temperature

18-28°C

≤ 4 hours

Refrigerated

 2-8°C

≤ 7 days

Frozen

≤-18 °C

≤ 6 months

Rejection Criteria

Gross Hemolysis

Result Reporting and Reference Values

Reported in mg/dL.

Age

Low

High

Critical Low

Critical High

0-30 days

0.0

0.6

N/A

N/A

30days- 150 years

0.0

0.3

N/A

N/A

Reflex Testing

None

Limitations

May be affected by several drugs including Levodopa, Methotrexate, Nitrofurantoin, Phenazopyridine, Piroxicam, Sulfasalazine, Triamterene; if results are questionable consider a possible interferent.